The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
14 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $4,663,430 in first-year total cost, median $348,754.
Most frequent study sections
- Special Emphasis Panel[ZRG1 AARR-K (52)]6
- Special Emphasis Panel[ZRG1 AARR-K (53)]5
- Special Emphasis Panel[ZRG1 IDM-C (52)]3
Most frequent institutions
- UNIVERSITY OF CAPE TOWN5
- STELLENBOSCH UNIVERSITY3
- WITS HEALTH CONSORTIUM (PTY), LTD3
- CENTRE/AIDS PROGRAMME/RES/SOUTH AFRICA2
- DESMOND TUTU HIV FOUNDATION1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2015 | Hormone induced mucosal susceptibility and HIV risk in South African adolescents1R01HD083040-01 | JASPAN, HEATHER BERYLPASSMORE, JO-ANN SHELLEY | UNIVERSITY OF CAPE TOWN | $353,627 | ZRG1 |
| 2015 | Altered immune-endocrine axis in type 2 diabetes and tuberculosis risk1R01AI116039-01 | RESTREPO, BLANCA IRONACHER, KATHARINA | STELLENBOSCH UNIVERSITY | $350,000 | ZRG1 |
| 2015 | Timing of establishment of the HIV latent reservoir in subtype C infected women1R01AI115981-01 | SWANSTROM, RONALD IWILLIAMSON, CAROLYN | UNIVERSITY OF CAPE TOWN | $350,000 | ZRG1 |
| 2015 | Design and delivery of combination HIV prevention in young South African women1R01MH107251-01 | BEKKER, LINDA-GAIL GAILCELUM, CONNIE L | DESMOND TUTU HIV FOUNDATION | $350,000 | ZRG1 |
| 2015 | Pharmacometric optimization of second line drugs for MDR tuberculosis treatment1R01AI116155-01 | GUMBO, TAWANDAMCILLERON, HELEN | UNIVERSITY OF CAPE TOWN | $349,997 | ZRG1 |
| 2015 | Innovations in HIV testing to enhance care for young women and their partners1R01HD083033-01 | KAHN, KATHLEENPETTIFOR, AUDREY | WITS HEALTH CONSORTIUM (PTY), LTD | $349,960 | ZRG1 |
| 2015 | HIV's Effects on Breast Cancer Treatment and Outcomes in South Africa1R01CA192627-01 | JACOBSON, JUDITH SJOFFE, MAUREENNEUGUT, ALFRED I.RUFF, PAUL | WITS HEALTH CONSORTIUM (PTY), LTD | $349,644 | ZRG1 |
| 2015 | Using Information to Align Services and Link and Retain Men in the HIV Cascade1R01MH106600-01 | COLVIN, CHRISTOPHER JAMESLURIE, MARK NATHAN | UNIVERSITY OF CAPE TOWN | $347,863 | ZRG1 |
| 2015 | Identifying sources of HIV infection in adolescent girls in rural South Africa1R01HD083343-01 | KHARSANY, AYESHA BMKOHLER, HANS-PETER | CENTRE/AIDS PROGRAMME/RES/SOUTH AFRICA | $347,836 | ZRG1 |
| 2015 | Analysis of National Lab Database to evaluate the HIV treatment rollout in South Africa1R01AI115979-01 | FOX, MATTHEW ALEXANDER PEASEMASKEW, MHAIRI | WITS HEALTH CONSORTIUM (PTY), LTD | $347,697 | ZRG1 |
| 2015 | Screening for atherosclerotic vascular disease in HIV-infected children1R01HD083042-01 | HAUBRICH, RICHARD HINNES, STEVE | STELLENBOSCH UNIVERSITY | $344,545 | ZRG1 |
| 2015 | Optimizing and operationalizing pediatric drug-resistant tuberculosis treatment1R01HD083047-01 | GARCIA-PRATS, ANTHONY JOSEPHSAVIC, RADOJKA | STELLENBOSCH UNIVERSITY | $343,581 | ZRG1 |
| 2015 | Combination treatment for protection against HIV1 and pregnancy1R01HD083026-01 | HAPGOOD, JANET PATRICIAHEL, ZDENEK | UNIVERSITY OF CAPE TOWN | $331,607 | ZRG1 |
| 2015 | Immune mediators associated with HPV clearance as predictors of HIV acquisition1R01AI115983-01 | CELENTANO, DAVID D.LIEBENBERG, LENINE JULIE PHILLIPS | CENTRE/AIDS PROGRAMME/RES/SOUTH AFRICA | $147,073 | ZRG1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.